Integrated BioPharma, Inc. INBP
Set alert
0.17 USD -0.01 -2.94%
At close · Oct 30
0.165 Day range 0.165
0.14 52-week range 0.42
- YTD
- -54.17%
- 1 year
- -46.77%
- Open
- 0.165
- Prev close
- 0.17
- Mkt cap
- 5.12M
- Vol
- 16.49K
- Avg vol
- 8.83K
- EPS
- -0.09
- P/E
- 0.00
More statistics
- Low
- 0.165
- High
- 0.165
6M chart
Signals (30)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Oct 26, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 6, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 6, 2026 | 4 weeks ago |
| MACD: Buy Signal | Oct 6, 2026 | 4 weeks ago |
| SMA: Bearish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 23, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 18, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 9, 2026 | 1 month ago |
| SMA: Bullish | Aug 18, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
| RSI: Oversold | Jul 28, 2026 | 3 months ago |
Newest 20 of 30.
Financials — quick view
INBP Revenue — quarterly 12.91M
INBP Net income — quarterly -59.00K
INBP EPS — quarterly 0.00
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | 0.00 | 0.01 | — | — |
| Sep 20, 2024 | Jun 1, 2024 | 0.00 | 0.01 | — | — |
| May 10, 2024 | Mar 1, 2024 | 0.00 | 0.01 | — | — |
| Feb 12, 2024 | Dec 1, 2023 | 0.00 | -0.01 | — | — |
| Nov 9, 2023 | Sep 1, 2023 | 0.00 | 0.00 | — | — |
| Sep 15, 2023 | Jun 1, 2023 | 0.00 | 0.00 | — | — |
News
- Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2026
- Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026
- Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025
- Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions
- Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025
- Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025
- Integrated BioPharma Reports Results for its Quarter Ended March 31, 2025
- Integrated BioPharma Reports Results for its Quarter Ended December 31, 2024
- Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024
- Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Your note
Sign in to keep a note on INBP — it syncs with the Stock Master app.